[
  {
    "ts": "2026-02-06T13:00:00+00:00",
    "headline": "Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation",
    "summary": "Abbott (NYSE: ABT) today announced new clinical data from two late-breaking presentations at AF Symposium in Boston (February 5-7, 2026) that demonstrate the strong safety and efficacy of the company's minimally invasive therapies to treat people with atrial fibrillation (AFib). The results include 12-month findings that reinforce the long-term safety and performance of Abbott's Volt™ Pulsed Field Ablation (PFA) System, which were simultaneously published in JACC: Clinical Electrophysiology. Pos",
    "url": "https://finance.yahoo.com/news/breaking-data-presentations-showcase-safety-130000701.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "c124a4d3-522b-3da7-9d7b-fba6bfcf54fd",
      "content": {
        "id": "c124a4d3-522b-3da7-9d7b-fba6bfcf54fd",
        "contentType": "STORY",
        "title": "Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation",
        "description": "",
        "summary": "Abbott (NYSE: ABT) today announced new clinical data from two late-breaking presentations at AF Symposium in Boston (February 5-7, 2026) that demonstrate the strong safety and efficacy of the company's minimally invasive therapies to treat people with atrial fibrillation (AFib). The results include 12-month findings that reinforce the long-term safety and performance of Abbott's Volt™ Pulsed Field Ablation (PFA) System, which were simultaneously published in JACC: Clinical Electrophysiology. Pos",
        "pubDate": "2026-02-06T13:00:00Z",
        "displayTime": "2026-02-06T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/f18691a40e904ec242f27f518d385f89",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2hv.nEdfVX.91GD8xT4MQg--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/f18691a40e904ec242f27f518d385f89.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Sp55yIoBHt095Uz.C3_c9w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f18691a40e904ec242f27f518d385f89.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/breaking-data-presentations-showcase-safety-130000701.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/breaking-data-presentations-showcase-safety-130000701.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-06T14:00:04+00:00",
    "headline": "Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-attracting-investor-140004518.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "cf73f5c7-da5d-3bb4-a54e-06697356a9c5",
      "content": {
        "id": "cf73f5c7-da5d-3bb4-a54e-06697356a9c5",
        "contentType": "STORY",
        "title": "Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know",
        "description": "",
        "summary": "Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
        "pubDate": "2026-02-06T14:00:04Z",
        "displayTime": "2026-02-06T14:00:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9",
          "originalWidth": 1000,
          "originalHeight": 603,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YgRrCYuBdR1wa08RtjoPHQ--~B/aD02MDM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9.cf.webp",
              "width": 1000,
              "height": 603,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jAWLk_UfDMDSToA2irhEEg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-attracting-investor-140004518.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-attracting-investor-140004518.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-06T05:01:00+00:00",
    "headline": "Top Picks 2026- AbbVie Inc. ABBV",
    "summary": "AbbVie Inc. (ABBV) is a US-based biopharmaceutical company formed in 2013 as a spinoff from Abbott Laboratories (ABT). It’s a cutting-edge company with strong exposure to high-demand needs in immunology and oncology...and it has a terrific pipeline, maintains Tom Hutchinson, editor of Cabot Dividend Investor.",
    "url": "https://finance.yahoo.com/news/top-picks-2026-abbvie-inc-050100557.html",
    "source": "MoneyShow",
    "provider": "yfinance",
    "raw": {
      "id": "6dd4b7d9-0699-37a2-a358-331e91e40e89",
      "content": {
        "id": "6dd4b7d9-0699-37a2-a358-331e91e40e89",
        "contentType": "STORY",
        "title": "Top Picks 2026- AbbVie Inc. ABBV",
        "description": "",
        "summary": "AbbVie Inc. (ABBV) is a US-based biopharmaceutical company formed in 2013 as a spinoff from Abbott Laboratories (ABT). It’s a cutting-edge company with strong exposure to high-demand needs in immunology and oncology...and it has a terrific pipeline, maintains Tom Hutchinson, editor of Cabot Dividend Investor.",
        "pubDate": "2026-02-06T05:01:00Z",
        "displayTime": "2026-02-06T05:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/moneyshow_610/5c1c7a9d7b2118d461c2dafd218cddae",
          "originalWidth": 666,
          "originalHeight": 349,
          "caption": "chart",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5GRU7Has4Af_RscjEVT7lQ--~B/aD0zNDk7dz02NjY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moneyshow_610/5c1c7a9d7b2118d461c2dafd218cddae.cf.webp",
              "width": 666,
              "height": 349,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nyOQ_SpfbeAMTrKyo7WV9g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moneyshow_610/5c1c7a9d7b2118d461c2dafd218cddae.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MoneyShow",
          "url": "https://www.moneyshow.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-picks-2026-abbvie-inc-050100557.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-picks-2026-abbvie-inc-050100557.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]